il-12 dna plasmids
Gene therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1998 (NCT00406939)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Interleukin-12 subunit betaSupplementation
IL12B supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- il-12 dna plasmids
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04015700 | Phase 1 | Oct 31, 2019 | Washington University in St. Louis |
| NCT00991354 | Phase 1 | Nov 1, 2009 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00406939 | Phase 1 | Jun 1, 1998 | Baylor University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 1998 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2009 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1